Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma a-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Neurodegeneration Disease

NCT07498686 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT07498686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07498686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma a-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Neurodegeneration Disease
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2023
Completion date
December 23, 2026
Enrollment
458 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rt-quic